DelveInsight Business Research LLP

Contraceptive Drugs Market By Product Type (Oral Contraceptive Pills [Combination And Progestin-Only], Injectables, Topical Contraceptives [Gels & Jellies, Patches, And Creams]), By Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, And Others), and by geography is expected to grow at an appreciable CAGR forecast till 2027 owing to rising cases of unitended pregnancies across the globe as well as extensive product development activities in contraceptive drugs

Contraception Key Highlights 

• The Key Companies working for the Substance Use Disorder market are as follows Abbvie Inc, BAYER AG, Viatris Inc, Gedeon Richter Plc., Agile Therapeutics, Evofem Biosciences, Inc, Amneal Pharmaceuticals LLC, Pfizer Inc and many others 

• The Key Therapies working in the Substance Use Disorder market are  Doxycycline, AZD1981, Neovletta , Leios and many others.

• The Market Size of the Substance Use Disorder market is expected to be USD XX Million.

• The CAGR of the Substance Use Disorder market is expected to be XX%.

Contraception Overview

Birth control pills are a type of contraception that’s 99% effective at preventing pregnancy when taken consistently every day. The pill contains hormones that regulate menstruation, decrease PMS symptoms, lower the risk of ovarian and uterine cancers, improve acne, and treat endometriosis. There are two types of birth control pills. Both contain hormones that keep you from getting pregnant. Combination pills contain estrogen and progestin. This is the most common type. Progestin-only pills are also called “the minipill.” They may be better if you’re breastfeeding (chestfeeding) or have a history of clots in your legs or lungs (venous thromboembolism) or stroke and shouldn’t take estrogen.

 Contraception Epidemiology Insights

• More than 42 million years of healthy life loss (DALY) were attributable to drug use, which is about 1.3% of the global burden of disease. It is estimated that worldwide there are almost 11 million people who inject drugs, of whom 1.4 million live with HIV and 5.6 million.

Click here to learn more about the Contraception Market Landscape

The Report Covers the Contraception  Epidemiology Segmented by:

• Total Contraception incident cases 

• Total Contraception prevalent cases 

• Total Contraception treatment cases 

• Total Contraception diagnostic cases 

Contraception Market Outlook 

The Substance (Drug) Abuse market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Substance (Drug) Abuse market trends by analyzing the impact of current Substance (Drug) Abuse therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of the Substance (Drug) Abuse market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Substance (Drug) Abuse market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the Substance (Drug) Abuse market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Contraception Market

• Abbvie Inc

• BAYER AG

• Viatris Inc

• Gedeon Richter Plc.

• Agile Therapeutics

• Evofem Biosciences, Inc.

And many others.

Contraception Therapies Covered and Analyzed in the Report:

• AZD1981

• Neovletta

• Lybrel

And many others 

Learn more about the Key Companies and Emerging Therapies in the Contraception Market

 Table of Contents 

1. Key Insights 

2. Contraception  Introduction 

3. Executive Summary of Contraception         

4. Disease Background and Overview

5. Epidemiology and patient population

6. Contraception  Emerging Therapies

7. Contraception  Market Outlook

8. Market Access and Reimbursement of Therapies

9. Market Drivers 

10. Market Barriers 

11. Appendix

12. Report Methodology

13. DelveInsight Capabilities

14. Disclaimer

Learn about the detailed offerings of the report @ Contraception Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services